{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:45:18Z","timestamp":1771303518747,"version":"3.50.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,3,14]],"date-time":"2003-03-14T00:00:00Z","timestamp":1047600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s00259-003-1136-y","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T21:57:14Z","timestamp":1282514234000},"page":"615-630","source":"Crossref","is-referenced-by-count":68,"title":["Non-invasive in vivo imaging of myocardial apoptosis and necrosis"],"prefix":"10.1007","volume":"30","author":[{"given":"Albert","family":"Flotats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,14]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"crossref","unstructured":"Narula J, Zaret BL. Noninvasive detection of cell death: from tracking epitaphs to counting coffins. J Nucl Cardiol 2002; 9:554\u2013560.","DOI":"10.1067\/mnc.2002.128765"},{"key":"1136_CR2","doi-asserted-by":"crossref","unstructured":"Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163\u20131170.","DOI":"10.1056\/NEJM200004203421603"},{"key":"1136_CR3","doi-asserted-by":"crossref","unstructured":"Rude RE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983; 52:936\u2013942.","DOI":"10.1016\/0002-9149(83)90508-8"},{"key":"1136_CR4","doi-asserted-by":"crossref","unstructured":"Holman BL, Lesch M, Zweiman FG. Detection and sizing of acute myocardial infarcts with99mTc(SN)tetracycline. N Engl J Med 1974; 291:159\u2013163.","DOI":"10.1056\/NEJM197407252910401"},{"key":"1136_CR5","doi-asserted-by":"crossref","unstructured":"Bonte FJ, Parkey RW, Graham KD, Mohr J, Stokely EM. A new method for radionuclide imaging of myocardial infarcts. Radiology 1974; 110:473\u2013474.","DOI":"10.1148\/110.2.473"},{"key":"1136_CR6","doi-asserted-by":"crossref","unstructured":"Beller GA, Khaw BA, Haber E, Smith TW. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Circulation 1977; 55:74\u201378.","DOI":"10.1161\/01.CIR.55.1.74"},{"key":"1136_CR7","unstructured":"Orlandi C, Crane PD, Edwards S, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med 1991; 32:236\u2013238."},{"key":"1136_CR8","doi-asserted-by":"crossref","unstructured":"Khaw BA. The current role of infarct avid imaging. Semin Nucl Med 1999; 29:259\u2013270.","DOI":"10.1016\/S0001-2998(99)80014-2"},{"key":"1136_CR9","unstructured":"Rude R, Parkey RW, Bonte FJ, et al. Clinical implication of the \"doughnut\" pattern of uptake in myocardial imaging with technetium-99 stannous pyrophosphate. Circulation 1977; 56:m-561."},{"key":"1136_CR10","doi-asserted-by":"crossref","unstructured":"Corbett JR, Lewis M, Willerson JT, et al. 99m-Tc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. Circulation 1984; 69:1120\u20131128.","DOI":"10.1161\/01.CIR.69.6.1120"},{"key":"1136_CR11","doi-asserted-by":"crossref","unstructured":"Massie BM, Botvinick EH, Werner JA, et al. Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction. Am J Cardiol 1979; 43:186\u2013192.","DOI":"10.1016\/S0002-9149(79)80003-X"},{"key":"1136_CR12","doi-asserted-by":"crossref","unstructured":"Khaw BA, Gold HK, Fallon JT, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of cardiac myosin specific antibody. Circulation 1986; 74:501\u2013508.","DOI":"10.1161\/01.CIR.74.3.501"},{"key":"1136_CR13","unstructured":"Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarction imaging with indium-111 labeled monoclonal antimyosin Fab fragments. J Nucl Med 1987; 28:1671\u20131678."},{"key":"1136_CR14","doi-asserted-by":"crossref","unstructured":"Khaw BA, Gold HK, Leinbach RC, et al. Early imaging of experimental myocardial infarction by intracoronary administration of131I-labeled anticardiac myosin (Fab')2 fragments. Circulation 1978; 58:1137\u20131142.","DOI":"10.1161\/01.CIR.58.6.1137"},{"key":"1136_CR15","doi-asserted-by":"crossref","unstructured":"Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979; 60:1527\u20131531.","DOI":"10.1161\/01.CIR.60.7.1527"},{"key":"1136_CR16","doi-asserted-by":"crossref","unstructured":"Khaw BA, Scott J, Fallon JT, et al. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science 1982; 217:1050\u20131053.","DOI":"10.1126\/science.7051286"},{"key":"1136_CR17","doi-asserted-by":"crossref","unstructured":"Khaw BA, Mattis JA, Melincoff G, et al. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma 1984; 3:11\u201323.","DOI":"10.1089\/hyb.1984.3.11"},{"key":"1136_CR18","doi-asserted-by":"crossref","unstructured":"Narula J, Southern JF, Dec GW, et al. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy. J Nucl Cardiol 1995; 2:470\u2013477.","DOI":"10.1016\/S1071-3581(05)80038-8"},{"key":"1136_CR19","unstructured":"Carri\u00f3 I, Bern\u00e0 L, Ballester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29:1893\u20131900."},{"key":"1136_CR20","unstructured":"Carri\u00f3 I, L\u00f3pez-Pousa A, Estorch M, et al. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. J Nucl Med 1993; 34:1503\u20131507."},{"key":"1136_CR21","unstructured":"Nishimura T, Nagata S, Uehara T, et al. Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antimyosin Fab myocardial scintigraphy. J Nucl Med 1991; 32:1333\u20131337."},{"key":"1136_CR22","doi-asserted-by":"crossref","unstructured":"Johnson LL, Seldin DW, Becker LC, et al. Antimyosin imaging in acute transmural myocardial infarction: results of a multicenter clinical trial. J Am Coll Cardiol 1989; 13:27\u201335.","DOI":"10.1016\/0735-1097(89)90544-5"},{"key":"1136_CR23","unstructured":"Nedelman MA, Shealy DK, Boulin R, et al. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single chain Fv: evaluation in a canine model of acute myocardial infarction. J Nucl Med 1993; 34:234\u2013241."},{"key":"1136_CR24","unstructured":"Tamaki N, Yamada T, Matsumori A, et al. Indium-111 antimyosin monoclonal antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging. J Nucl Med 1990; 31:136\u2013142."},{"key":"1136_CR25","unstructured":"Frist W, Yasuda T, Segall G, et al. Noninvasive detection of human cardiac transplant rejection with In-111 antimyosin (Fab) imaging. Circulation 1987; 76 (Suppl V): 81\u201385."},{"key":"1136_CR26","doi-asserted-by":"crossref","unstructured":"Ballester M, Obrador D, Carri\u00f3 I, et al.111In-monoclonal antimyosin antibody studies after the first year of heart transplantation: identification of risk groups for developing rejection during long-term follow-up and clinical implications. Circulation 1990; 82:2100\u20132108.","DOI":"10.1161\/01.CIR.82.6.2100"},{"key":"1136_CR27","doi-asserted-by":"crossref","unstructured":"Ballester M, Obrador D, Carri\u00f3 I, et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation 1992; 85:61\u201368.","DOI":"10.1161\/01.CIR.85.1.61"},{"key":"1136_CR28","doi-asserted-by":"crossref","unstructured":"Hosenpud JD. Noninvasive diagnosis of cardiac allograft rejection. Another of many searches for the grail. Circulation 1992; 85:368\u2013371.","DOI":"10.1161\/01.CIR.85.1.368"},{"key":"1136_CR29","doi-asserted-by":"crossref","unstructured":"Ballester M, Bordes R, Tazelaar T, et al. Evaluation of biopsy classification for rejection: relation to the detection of myocardial damage by 111-In-monoclonal antimyosin antibody imaging. J Am Coll Cardiol 1998; 31:1357\u20131361.","DOI":"10.1016\/S0735-1097(98)00084-9"},{"key":"1136_CR30","unstructured":"Estorch M, Carri\u00f3 I, Berna L, et al.111In-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med 1990; 31:1965\u20131969."},{"key":"1136_CR31","doi-asserted-by":"crossref","unstructured":"Carri\u00f3 I, Estorch M, Bern\u00e0 L, et al. Assessment of anthracycline induced myocardial damage by quantitative111In-antimyosin monoclonal antibody studies. Eur J Nucl Med 1991; 18:806\u2013812.","DOI":"10.1007\/BF00175059"},{"key":"1136_CR32","doi-asserted-by":"crossref","unstructured":"Vald\u00e9s Olmos RA, Carri\u00f3 I, Hoefnagel M, et al. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction. Nucl Med Commun 2002; 23:871\u2013877.","DOI":"10.1097\/00006231-200209000-00011"},{"key":"1136_CR33","doi-asserted-by":"crossref","unstructured":"Yasuda T, Palacios IF, Dec GW, et al. Indium-111 antimyosin monoclonal antibody imaging in the diagnosis of acute myocarditis. Circulation 1987; 76:306\u2013311.","DOI":"10.1161\/01.CIR.76.2.306"},{"key":"1136_CR34","doi-asserted-by":"crossref","unstructured":"Dec GW, Palacios IF, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990; 16:97\u2013104.","DOI":"10.1016\/0735-1097(90)90463-Y"},{"key":"1136_CR35","doi-asserted-by":"crossref","unstructured":"Narula J, Khaw BA, Dec GW, et al. Recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 1992; 328:100\u2013104.","DOI":"10.1056\/NEJM199301143280205"},{"key":"1136_CR36","doi-asserted-by":"crossref","unstructured":"Obrador D, Ballester M, Carri\u00f3 I, et al. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989; 13:1289\u20131293.","DOI":"10.1016\/0735-1097(89)90303-3"},{"key":"1136_CR37","doi-asserted-by":"crossref","unstructured":"Obrador D, Ballester M, Carri\u00f3 I, et al. Active myocardial damage without attending inflammatory response in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993; 21:1667\u20131671.","DOI":"10.1016\/0735-1097(93)90385-E"},{"key":"1136_CR38","doi-asserted-by":"crossref","unstructured":"Obrador D, Ballester M, Carri\u00f3 I, et al. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by111In monoclonal antimyosin antibodies. Circulation 1994; 89:2054\u20132061.","DOI":"10.1161\/01.CIR.89.5.2054"},{"key":"1136_CR39","doi-asserted-by":"crossref","unstructured":"Pons-Llado G, Ballester M, Borras X, et al. Myocardial cell damage in human hypertension. J Am Coll Cardiol 2000; 36:2198\u20132203.","DOI":"10.1016\/S0735-1097(00)00983-9"},{"key":"1136_CR40","doi-asserted-by":"crossref","unstructured":"Van Vlies B, Van Royen EA, Visser CA, et al. Frequency of myocardial indium-111 antimyosin uptake alter uncomplicated coronary artery bypass grafting. Am J Cardiol 1990; 66:1191\u20131195.","DOI":"10.1016\/0002-9149(90)91097-P"},{"key":"1136_CR41","unstructured":"Narula J. Pathologic basis for the role of antimyosin imaging for the detection of cardiac involvement in systemic disorders. In: Khaw BA, Narula J, Strauss WH, eds. Monoclonal antibodies in cardiovascular disease. Phildelphia: Lea and Febiger; 1994:118\u2013126."},{"key":"1136_CR42","doi-asserted-by":"crossref","unstructured":"Mart\u00ed V, Ballester M, Udina C, et al. Evaluation of myocardial cell damage by In-111 monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. Circulation 1995; 92:1619\u20131623.","DOI":"10.1161\/01.CIR.91.6.1619"},{"key":"1136_CR43","unstructured":"Mart\u00ed V, Ballester M, Obrador D, et al. Active myocardial damage in hyperthyroidism: a concurrent mechanism of heart failure reversed by treatment. Eur Heart J 1995; 16:1014\u20131016."},{"key":"1136_CR44","doi-asserted-by":"crossref","unstructured":"Mart\u00ed V, Ballester M, Rigla M, et al. Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure. Am Heart J 1997; 134:1133\u20131137.","DOI":"10.1016\/S0002-8703(97)70036-X"},{"key":"1136_CR45","doi-asserted-by":"crossref","unstructured":"Ewer MS, Ali MK, Mackey B, et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adryamicin. J Clin Oncol 1984; 2:112\u2013117.","DOI":"10.1200\/JCO.1984.2.2.112"},{"key":"1136_CR46","doi-asserted-by":"crossref","unstructured":"Sarda L, Colin P, Boccara F, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001; 37:786\u2013792.","DOI":"10.1016\/S0735-1097(00)01201-8"},{"key":"1136_CR47","doi-asserted-by":"crossref","unstructured":"Mart\u00ed V, Aymat R, Ballester M, Garc\u00eda J, Carri\u00f3 I, Aug\u00e9 JM. Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy. Int J Cardiol 2002; 82:237\u2013245.","DOI":"10.1016\/S0167-5273(02)00003-7"},{"key":"1136_CR48","unstructured":"Flotats A, Domingo P, Carri\u00f3 I. Dilated cardiomyopathy in HIV-infected patients. N Engl J Med 1999; 340:733\u2013734."},{"key":"1136_CR49","unstructured":"Data on file. Centocor, Inc. Myoscint PLA 95\u20131210."},{"key":"1136_CR50","unstructured":"Mariani G, Villa G, Rossettin PF, et al. Detection of myocardial infarction by99mTc-labeled d-glucaric acid imaging in patients with acute chest pain. J Nucl Med 1999; 40:1832\u20131839."},{"key":"1136_CR51","doi-asserted-by":"crossref","unstructured":"Narula J, Petrov A, Pak KY, et al. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with99mTc-labeled glucarate. Circulation 1995; 95:1577\u20131584.","DOI":"10.1161\/01.CIR.95.6.1577"},{"key":"1136_CR52","doi-asserted-by":"crossref","unstructured":"Khaw BA, Nakazama A, O'Donell SM, et al. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997; 4:283\u2013290.","DOI":"10.1016\/S1071-3581(97)90105-7"},{"key":"1136_CR53","unstructured":"Fornet BB, Yasuda T, Wilkinson R, et al. Detection of acute cardiac injury with technetium-99m glucaric acid [abstract]. J Nucl Med 1989; 30:1743."},{"key":"1136_CR54","unstructured":"Yaoita H, Fischman AJ, Wilkinson R, et al. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993; 34:1303\u20131308."},{"key":"1136_CR55","unstructured":"Ohtani H, Callahan RJ, Khaw BA, et al. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med 1992; 33:1988\u20131993."},{"key":"1136_CR56","doi-asserted-by":"crossref","unstructured":"Beanlands RSB, Ruddy TD, Bielawsky L, et al. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. J Nucl Cardiol 1997; 4:274\u2013282.","DOI":"10.1016\/S1071-3581(97)90104-5"},{"key":"1136_CR57","doi-asserted-by":"crossref","unstructured":"Johnson LL, Schofield L, Mastrofrancesco P, Donahay T, Farb A, Khaw BA. Tc-99m glucarate uptake in a swine model of limited flow plus increased demand. J Nucl Cardiol 2000; 7:579\u2013588.","DOI":"10.1067\/mnc.2000.108908"},{"key":"1136_CR58","doi-asserted-by":"crossref","unstructured":"Khaw BA, Da Silva J, Petrov A, Hartner W. Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic necrosis. J Nucl Cardiol 2002; 9:471\u2013481.","DOI":"10.1067\/mnc.2002.124479"},{"key":"1136_CR59","doi-asserted-by":"crossref","unstructured":"Puig M, Ballester M, Mat\u00edas-Guiu X, et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of uptake of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J Nucl Cardiol 2000; 7:132\u2013139.","DOI":"10.1016\/S1071-3581(00)90033-3"},{"key":"1136_CR60","unstructured":"Blankenberg FG, Katsikis PD, Tait JF, et al. Comparison of Tc-99m glucarate uptake in apoptotic (programmed) and necrotic cell death [abstract]. J Nucl Med 1997; 38:192P."},{"key":"1136_CR61","doi-asserted-by":"crossref","unstructured":"Molea N, Lazzeri E, Bodei L, et al. Biodistribution pharmacokinetics and dosimetry of99mTc-d-glucaric acid in humans. In: Bergmann H, Kroiss A, Sinzinger H, eds. Radioactive isotopes in clinical medicine and research. XXI. Basel: Birkhauser; 1997:359\u2013364.","DOI":"10.1007\/978-3-0348-7772-5_54"},{"key":"1136_CR62","doi-asserted-by":"crossref","unstructured":"Flotats A, Narula J, Santal\u00f3 M, et al. Myocardial uptake of technetium-99m glucarate occurs in acute regional myocardial necrosis but not in diffuse ongoing myocardial damage [abstract]. J Nucl Cardiol 1999; 6 (Suppl):S100.","DOI":"10.1016\/S1071-3581(99)90514-7"},{"key":"1136_CR63","doi-asserted-by":"crossref","unstructured":"Gerson MC, McGoron AJ. Technetium 99m-glucarate: what will be its clinical role? J Nucl Cardiol 1997; 4:336\u2013340.","DOI":"10.1016\/S1071-3581(97)90112-4"},{"key":"1136_CR64","doi-asserted-by":"crossref","unstructured":"Blankenberg F, Narula J, Strauss HW. In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocaditis, ischemia, and heart failure. J Nucl Cardiol 1999; 6:531\u2013539.","DOI":"10.1016\/S1071-3581(99)90026-0"},{"key":"1136_CR65","doi-asserted-by":"crossref","unstructured":"Holly TA, Drincic A, Byaun Y, et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999; 31:1709\u20131715.","DOI":"10.1006\/jmcc.1999.1006"},{"key":"1136_CR66","doi-asserted-by":"crossref","unstructured":"Green DR. Apoptotic pathways: the roads to ruin. Cell 1998; 94:695\u2013698.","DOI":"10.1016\/S0092-8674(00)81728-6"},{"key":"1136_CR67","doi-asserted-by":"crossref","unstructured":"Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102:1\u20134.","DOI":"10.1016\/S0092-8674(00)00003-9"},{"key":"1136_CR68","doi-asserted-by":"crossref","unstructured":"van Heerde WL, Robert-Offerman S, Dumont E, et al. Markers of apoptosis in cardiovascular tissues: focus on annexin V. Cardiovasc Res 2000; 45:549\u2013559.","DOI":"10.1016\/S0008-6363(99)00396-X"},{"key":"1136_CR69","doi-asserted-by":"crossref","unstructured":"Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89:1121\u20131132.","DOI":"10.1182\/blood.V89.4.1121"},{"key":"1136_CR70","doi-asserted-by":"crossref","unstructured":"Martin SJ, Reutelingsperger CPM, McGahon AJ. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182:1545\u20131556.","DOI":"10.1084\/jem.182.5.1545"},{"key":"1136_CR71","doi-asserted-by":"crossref","unstructured":"Fadok VA, Bratton DL, Rose DM, et al. A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 2000; 405:85\u201390.","DOI":"10.1038\/35011084"},{"key":"1136_CR72","doi-asserted-by":"crossref","unstructured":"Strauss HW, Narula J, Blankenberg FG. Radioimaging to identify myocardial cell death and probably injury. Lancet 2000; 356:180\u2013181.","DOI":"10.1016\/S0140-6736(00)02474-0"},{"key":"1136_CR73","doi-asserted-by":"crossref","unstructured":"Romisch J, Paques EP. Annexins: calcium binding proteins of multifunctional importance? Med Microbiol Immunol 1991; 180:109\u2013126.","DOI":"10.1007\/BF00206115"},{"key":"1136_CR74","doi-asserted-by":"crossref","unstructured":"van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromb Haemost 1995; 73:172\u2013179.","DOI":"10.1055\/s-0038-1653747"},{"key":"1136_CR75","doi-asserted-by":"crossref","unstructured":"Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR. Evaluation of annexin V as a platelet directed thrombus targeting agent. Thromb Res 1994; 75:491\u2013501.","DOI":"10.1016\/0049-3848(94)90224-0"},{"key":"1136_CR76","doi-asserted-by":"crossref","unstructured":"Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995; 92:3113\u20133121.","DOI":"10.1161\/01.CIR.92.10.3113"},{"key":"1136_CR77","doi-asserted-by":"crossref","unstructured":"Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, vanOers MHJ. Annexin V for cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415\u20131420.","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415"},{"key":"1136_CR78","doi-asserted-by":"crossref","unstructured":"Boersma AMW, Kees N, Oostrum RG, Stoter RG. Quantification of apoptotic cells with fluorescein isothiocynate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996; 24:123\u2013130.","DOI":"10.1002\/(SICI)1097-0320(19960601)24:2<123::AID-CYTO4>3.0.CO;2-K"},{"key":"1136_CR79","doi-asserted-by":"crossref","unstructured":"Bennett MR, Gibson DF, Schwart S, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995; 77:1136\u20131142.","DOI":"10.1161\/01.RES.77.6.1136"},{"key":"1136_CR80","doi-asserted-by":"crossref","unstructured":"Tait JF, Smith C, Wood BL. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V. Blood Cells Mol Dis 1999; 25:271\u2013278.","DOI":"10.1006\/bcmd.1999.0254"},{"key":"1136_CR81","unstructured":"Dischman AJ, Khaw BA, Strauss HW. Quo vadis radioimmune imaging. J Nucl Med 1999; 30:1911\u20131915."},{"key":"1136_CR82","doi-asserted-by":"crossref","unstructured":"Gidon-Jeangirard C, Solito E, Hofmann A, et al. Annexin V counteracts apoptosis while inducing Ca2+ influx in human lymphocytic T cells. Biochem Biophys Res Commun 1999; 265:709\u2013715.","DOI":"10.1006\/bbrc.1999.1752"},{"key":"1136_CR83","doi-asserted-by":"crossref","unstructured":"Kaneko N, Matsuda R, Hosoda S, et al. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996; 251:65\u201380.","DOI":"10.1016\/0009-8981(96)06294-8"},{"key":"1136_CR84","doi-asserted-by":"crossref","unstructured":"van den Eijnde SM, Luijsterburg AJ, Boshart L, et al. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry 1997; 29:313\u2013320.","DOI":"10.1002\/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A"},{"key":"1136_CR85","doi-asserted-by":"crossref","unstructured":"Dumont EA, Hofstra L, van Heerde WL, et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 2000; 102:1564\u20131568.","DOI":"10.1161\/01.CIR.102.13.1564"},{"key":"1136_CR86","doi-asserted-by":"crossref","unstructured":"Dumont EA, Reutelingsperger CP, Smits JF, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 2001; 7:1352\u20131355.","DOI":"10.1038\/nm1201-1352"},{"key":"1136_CR87","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1073\/pnas.95.11.6349","volume":"95","author":"Blankenberg","year":"1998","unstructured":"Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphtidylserine expression during programmed cell death. Proc Natl Acad Sci U S A 1998; 95:6349\u20136354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1136_CR88","doi-asserted-by":"crossref","unstructured":"Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996; 88:1873\u20131880.","DOI":"10.1182\/blood.V88.5.1873.1873"},{"key":"1136_CR89","doi-asserted-by":"crossref","unstructured":"Tait JF, Engelhardt S, Smith C, Fujikawa K. Pro-urokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins. J Biol Chem 1995; 270:21594\u201321599.","DOI":"10.1074\/jbc.270.37.21594"},{"key":"1136_CR90","doi-asserted-by":"crossref","unstructured":"Tait JF, Smith C. Site-specific mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipids binding. Arch Biochem Biophys 1991; 288:141\u2013144.","DOI":"10.1016\/0003-9861(91)90175-I"},{"key":"1136_CR91","unstructured":"Abrams MJ, Juweid M, tenKate CI, et al. Technetium-99m-human polyclonal IgG radiloabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31:2022\u20132028."},{"key":"1136_CR92","doi-asserted-by":"crossref","unstructured":"Larsen SK, Solomon HF, Caldwell G, Abrams MJ. [99mTc]tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconjug Chem 1995; 6:635\u2013638.","DOI":"10.1021\/bc00035a020"},{"key":"1136_CR93","unstructured":"Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell death) with99mTc annexin V. J Nucl Med 1999; 40:184\u2013191."},{"key":"1136_CR94","doi-asserted-by":"crossref","unstructured":"Ohtsuki K, Akashi K, Aoka Y, et al.99mTc-HYNIC annexin V: a radiopharmaceutical for the in vivo detection of apoptosis. Eur J Nucl Med 1999; 26:1251\u20131258.","DOI":"10.1007\/s002590050580"},{"key":"1136_CR95","doi-asserted-by":"crossref","unstructured":"Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116:844\u2013853.","DOI":"10.1016\/S0022-5223(98)00446-2"},{"key":"1136_CR96","doi-asserted-by":"crossref","unstructured":"Ogura Y, Krams SM, Martinez OM, et al. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000; 214:795\u2013800.","DOI":"10.1148\/radiology.214.3.r00mr34795"},{"key":"1136_CR97","doi-asserted-by":"crossref","unstructured":"Blankenberg FG, Robbins RC, Stoot JH, et al. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest 2000; 117:834\u2013840.","DOI":"10.1378\/chest.117.3.834"},{"key":"1136_CR98","doi-asserted-by":"crossref","unstructured":"D'Arceuil HE, Rhine W, de Crespigny A, et al.99mTc Annexin V imaging of neonatal hypoxic brain injury. Stroke 2000; 32:2692\u20132700.","DOI":"10.1161\/01.STR.31.11.2692"},{"key":"1136_CR99","unstructured":"Blankenberg FG, Naumovski K, Tait JF, Post AM, Strauss HW. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using99mTc-radiolabeled annexin. J Nucl Med 2001; 42:309\u2013316."},{"key":"1136_CR100","unstructured":"Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med 2002; 43:1359\u20131365."},{"key":"1136_CR101","doi-asserted-by":"crossref","unstructured":"Tokita N, Hasegawa S, Maruyama K, et al.99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med 2003; 30:232\u2013238.","DOI":"10.1007\/s00259-002-1006-z"},{"key":"1136_CR102","unstructured":"Kemerink GJ, Liem IH, Hofstra L, et al. Patient dosimetry of intravenously administered99mTc-annexin V. J Nucl Med 2001; 42:382\u2013387."},{"key":"1136_CR103","doi-asserted-by":"crossref","unstructured":"Kemerink GJ, Boersma HH, Thimister PWL, et al. Biodistribution and dosimetry of99mTc-BTAP-annexin-V. Eur J Nucl Med 2001; 28:1373\u20131378.","DOI":"10.1007\/s002590100578"},{"key":"1136_CR104","doi-asserted-by":"crossref","unstructured":"Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356:209\u2013212.","DOI":"10.1016\/S0140-6736(00)02482-X"},{"key":"1136_CR105","doi-asserted-by":"crossref","unstructured":"Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001; 7:1347\u20131352.","DOI":"10.1038\/nm1201-1347"},{"key":"1136_CR106","doi-asserted-by":"crossref","unstructured":"Kown HM, Strauss HM, Blankenberg FG, et al. In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin. Am J Transplant 2001; 1:270\u2013277.","DOI":"10.1034\/j.1600-6143.2001.001003270.x"},{"key":"1136_CR107","doi-asserted-by":"crossref","unstructured":"Myocardial Infarction Redefined\u2014A Consensus Document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 3:959\u2013969.","DOI":"10.1016\/S0735-1097(00)00804-4"},{"key":"1136_CR108","unstructured":"Li C, Wen X, Wu Q, et al. Apoptosis induced by drug treatments correlates with uptake of 111-In-labeled PEGylated annexin V in MDA-MB468 tumors. J Nucl Med 2002; 43 (Suppl):41P."},{"key":"1136_CR109","unstructured":"Russell J, O'Donoghue JA, Finn R, et al. Iodination of annexin V for imaging apoptosis. J Nucl Med 2002; 43:671\u2013677."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-003-1136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-003-1136-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-003-1136-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T20:42:51Z","timestamp":1591821771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-003-1136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,14]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1007\/s00259-003-1136-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,14]]}}}